Results 151 to 160 of about 1,766,409 (315)
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Spontaneous neoplasms in fishes. V. Acinar adenocarcinoma of the pancreas in a hybrid platyfish
Ross F. Nigrelli, Myron Gordon
openalex +1 more source
THE DIAGNOSIS OF NEOPLASMS FROM MICROSCOPIC EXAMINATION OF TRANSUDES [PDF]
NULL AUTHOR_ID
openalex +1 more source
Risk of malignant neoplasms of tacrolimus in kidney transplant patients: a retrospective cohort study conducted using the Japanese National Database of Health Insurance Claims. [PDF]
Kubota R+17 more
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Are thrombosis, progression, and survival in ET predictable?
Ghaith Abu-Zeinah+7 more
doaj +1 more source
Two Unusual Small Intestinal Neoplasms, both with Anaemia [PDF]
Jim Richardson
openalex +1 more source
Malignant cutaneous adnexal neoplasms with distant brain metastasis: an aggressive behavior. Illustrative cases. [PDF]
Vargas-Urbina J+5 more
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source